Early pregnancy loss (< 10 weeks of gestation)
Conditions
Brief summary
Complete trophoblastic tissue expulsion, measured by the presence of a retained product of conception (RPOC) at ultrasound and diagnostic hysteroscopy ~1-2 month following intervention and the need for a secondary hysteroscopic resection
Detailed description
Intra-uterine adhesion rates at diagnostic hysteroscopy 1-2 months following complete evacuation, Pregnancy rates in the year following randomization, Rate of successful genetic analysis on the product of conception, Time needed to conceive, Complications occurring until 30 days post treatment, Patient well-being and quality of life evaluated by questionnaires 1-month and 3-months after the procedure
Interventions
DRUGMifegyne 200 mg comprimés - FR
DRUGMifegyne 200 mg Tabletten - DE
DRUGCYTOTEC 200 microgrammes
DRUGcomprimés.
DRUGMifegyne 200 mg tabletten - NL
DRUGCYTOTEC 200 microgram tabletten.
DRUGCytotec 200 Mikrogramm Tabletten
Sponsors
UZ Brussel
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete trophoblastic tissue expulsion, measured by the presence of a retained product of conception (RPOC) at ultrasound and diagnostic hysteroscopy ~1-2 month following intervention and the need for a secondary hysteroscopic resection | — |
Secondary
| Measure | Time frame |
|---|---|
| Intra-uterine adhesion rates at diagnostic hysteroscopy 1-2 months following complete evacuation, Pregnancy rates in the year following randomization, Rate of successful genetic analysis on the product of conception, Time needed to conceive, Complications occurring until 30 days post treatment, Patient well-being and quality of life evaluated by questionnaires 1-month and 3-months after the procedure | — |
Countries
Belgium
Outcome results
None listed